Evidence map›Paper›PMID 39829204›Full record

ArticleAging cell2025

From Clinical to Benchside: Lacticaseibacillus and Faecalibacterium Are Positively Associated With Muscle Health and Alleviate Age-Related Muscle Disorder.

Chaoran Liu, Pui Yan Wong, Nilakshi Barua, Baoqi Li, Hei Yuet Wong, Ning Zhang, Simon Kwoon Ho Chow, Sunny Hei Wong, Jun Yu, Margaret Ip and 5 more

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chaoran LiuDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Pui Yan WongDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Nilakshi BaruaDepartment of Microbiology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Baoqi LiDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Hei Yuet WongDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ning ZhangDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Simon Kwoon Ho ChowDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Palo Alto, California, USA.
Sunny Hei WongLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Jun YuDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Margaret IpDepartment of Microbiology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Wing Hoi CheungDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-3247-8255
Gustavo DuqueBone, Muscle & Geroscience Research Group, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Christoph BrochhausenInstitute of Pathology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Joseph Jao Yiu SungLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Ronald Man Yeung WongDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-5615-6627

Funding

Collaborative Research Fund, HKSAR Research Grants Council C4032-21GFGeneral Research Fund, HKSAR Research Grants Council 14116223
6 · The paper itself

Abstract

Sarcopenia is an age-related muscle disorder that increases risks of adverse clinical outcomes, but its treatments are still limited. Gut microbiota is potentially associated with sarcopenia, and its role is still unclear. To investigate the role of gut microbiota in sarcopenia, we first compared gut microbiota and metabolites composition in old participants with or without sarcopenia. Fecal microbiota transplantation (FMT) from human donors to antibiotic-treated recipient mice was then performed. Specific probiotics and their mechanisms to treat aged mice were identified. Old people with sarcopenia had different microbial composition and metabolites, including Paraprevotella, Lachnospira, short-chain fatty acids, and purine. After FMT, mice receiving microbes from people with sarcopenia displayed lower muscle mass and strength compared with those receiving microbes from non-sarcopenic donors. Lacticaseibacillus rhamnosus (LR) and Faecalibacterium prausnitzii (FP) were positively related to muscle health of old people, and enhanced muscle mass and function of aged mice. Transcriptomics showed that genes related to tricarboxylic acid cycle (TCA) were enriched after treatments. Metabolic analysis showed increased substrates of TCA cycle in both LR and FP supernatants. Muscle mitochondria density, ATP content, NAD

Indexed as

Gastrointestinal MicrobiomeSarcopeniaAgedAgingAnimalsFecal Microbiota TransplantationFemaleHumansLacticaseibacillusMaleMiceProbioticsagingfecal microbiota transplantationgut microbiotamuscleprobioticsarcopenia

Identifiers

PMID39829204
PMCPMC12073917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.